| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/09/2006 | EP1687430A1 Immunization against chlamydia infection |
| 08/09/2006 | EP1687427A2 Methods for modulating neuronal responses |
| 08/09/2006 | EP1687426A2 Antiangiogenicpeptides for treating or preventing endometriosis |
| 08/09/2006 | EP1687420A1 Carboxypertidase u (cpu) mutants |
| 08/09/2006 | EP1687402A2 Chimeric metabotropic glutamate receptors and uses thereof |
| 08/09/2006 | EP1687337A1 A method for the treatment of malignant diseases by inhibiting nucleolin |
| 08/09/2006 | EP1687333A2 Method for down-regulation of vegf |
| 08/09/2006 | EP1687332A2 Polynucleotides overexpressed in breast cancer cells , compositions and methods for the therapy and diagnosis of breast cancer |
| 08/09/2006 | EP1687331A1 Tyrosine phosphorylation of cdk inhibitor proteins of the cip/kip family |
| 08/09/2006 | EP1687330A1 Peptides with anti-obesity activity and other related uses |
| 08/09/2006 | EP1687327A2 Novel heat shock protein 20-related polypeptides and uses therefor |
| 08/09/2006 | EP1687304A1 Substituted quinolines for the treatment of cancer |
| 08/09/2006 | EP1687065A2 Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
| 08/09/2006 | EP1687043A2 Electrical devices and anti-scarring agents |
| 08/09/2006 | EP1687032A1 Therapeutic regimen for treating cancer |
| 08/09/2006 | EP1687021A1 Method of removing transition metals, especially from metathesis reaction products |
| 08/09/2006 | EP1687020A1 Therapeutic use of factor xi |
| 08/09/2006 | EP1687019A2 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
| 08/09/2006 | EP1687018A1 Hepatitis c virus inhibitors |
| 08/09/2006 | EP1687017A2 Methods and compositions for delivering polynucleotides |
| 08/09/2006 | EP1687016A2 Diphtheria toxin variant |
| 08/09/2006 | EP1687011A2 Modified whole cell, cell extract and omv-based vaccines |
| 08/09/2006 | EP1687010A1 Autologous treatment of degenerated disc with cells |
| 08/09/2006 | EP1686998A1 Phosphodiesterase 9 inhibition as treatment for obesity-related conditions |
| 08/09/2006 | EP1686964A1 Microparticles comprising somatostatin analogues |
| 08/09/2006 | EP1686958A1 Controlled food effect composition |
| 08/09/2006 | EP1686957A1 Compositions containing mixtures of tetrapeptides and tripeptides |
| 08/09/2006 | EP1686951A1 Combined cosmetic or therapeutic preparation |
| 08/09/2006 | EP1594520B1 Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis |
| 08/09/2006 | EP1549951A4 Semaphorin-like proteins and methods of using same |
| 08/09/2006 | EP1448179B1 Substituted bicyclo 3.3.1 nonan-2,4,9-triones as pharmaceutical active ingredients |
| 08/09/2006 | EP1354032B1 Gene regulation therapy involving ferritin |
| 08/09/2006 | EP1307481B1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 08/09/2006 | EP1267954B1 Medical devices suitable for gene therapy regimens |
| 08/09/2006 | EP1183275B1 Specific antibodies against human chorionic gonadotropin and their use in therapy and diagnostic |
| 08/09/2006 | EP1177197B1 Polyamines and their use in therapy |
| 08/09/2006 | EP1171157B1 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 08/09/2006 | EP1165099B1 Angiotensin ii and analogs thereof for limiting scar and adhesion formation |
| 08/09/2006 | EP1144003B1 Methods and devices for delivery of agents to breast milk ducts |
| 08/09/2006 | EP1133319B1 Photosensitizer conjugates for targeting intracellular pathogens |
| 08/09/2006 | EP1069135B1 Proteins having immunomodulatory activity and remedies for immunological diseases |
| 08/09/2006 | EP1051619B1 Method for identifying t-cell stimulating protein fragments |
| 08/09/2006 | EP1044014B1 Agent for treating allergic or hypersensitivity condition |
| 08/09/2006 | EP1037650B1 Compositions for the treatment of staphylococcus aureus infections |
| 08/09/2006 | EP1030678B1 High throughput method for functionally classifying proteins identified using a genomics approach |
| 08/09/2006 | EP1012177B1 Estrogen receptor |
| 08/09/2006 | EP1007092B1 A process for inhibiting complement activation via the alternative pathway |
| 08/09/2006 | EP1005487B1 The 74 kilodalton outer membrane protein from moraxella catarrhalis |
| 08/09/2006 | EP0988316B1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 08/09/2006 | EP0981607B1 Modified arginine deiminase |
| 08/09/2006 | EP0951472B1 Peptide compositions with growth factor-like activity |
| 08/09/2006 | EP0935656B1 Hedgehog interacting proteins and uses related thereto |
| 08/09/2006 | EP0920305B1 Identification of genes altered in multiple myeloma |
| 08/09/2006 | EP0910659B1 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 08/09/2006 | EP0759988B1 NUCLEIC ACIDS OF $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) AND METHODS AND COMPOSITIONS FOR DIAGNOSING $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) INFECTION |
| 08/09/2006 | EP0752004B1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 08/09/2006 | CN1816627A Method for producing glucoamylases and their uses |
| 08/09/2006 | CN1816625A Dna-based aptamers for human cathepsin g |
| 08/09/2006 | CN1816566A VEGF traps and therapeutic uses thereof |
| 08/09/2006 | CN1816565A INF-like secretory protein |
| 08/09/2006 | CN1816564A Rasgap derived peptide for selectively killing cancer cells |
| 08/09/2006 | CN1816561A Antimicrobial polypeptides |
| 08/09/2006 | CN1816538A Preventive or therapeutic composition for viral infectious disease |
| 08/09/2006 | CN1816353A Medicinal composition for preventing or treating Th1 type immunological disease |
| 08/09/2006 | CN1816349A Compositions and methods for WT1 specific immunotherapy |
| 08/09/2006 | CN1816347A Human serum albumin-free stabilised interferon liquid formulations |
| 08/09/2006 | CN1816346A Abuse resistant amphetamine compounds |
| 08/09/2006 | CN1816345A Preventive and/or remedy for diseases accompanied by tissue destruction |
| 08/09/2006 | CN1816326A Composition of a VEGF antagonist and an anti-proliferative agent and usage in cancer treatment thereof |
| 08/09/2006 | CN1816324A Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |
| 08/09/2006 | CN1814621A Malania oeifera protein for human cancer treatment |
| 08/09/2006 | CN1814618A Japanese schistosome metalloproteuse minic peptide and its screening method and use |
| 08/09/2006 | CN1814614A Nucleic acid, peptide nucleicacid derivatives and their use |
| 08/09/2006 | CN1814295A Method for preparing gene therapeutic tissue engineering stent |
| 08/09/2006 | CN1814294A Corn SOD liposome and its preparing method |
| 08/09/2006 | CN1814287A Prevention and treatment of amyloidogenic disease |
| 08/09/2006 | CN1814284A Method for raising utilizing degree to oral organism-absorbing of lumbrukinase |
| 08/09/2006 | CN1814283A Medicine composition for treating degestive ulcer |
| 08/09/2006 | CN1814282A Biological collagen oral liquor and preparing method |
| 08/09/2006 | CN1814281A Redfish calcitonin inhalation powder-atomizing agent and preparing method |
| 08/09/2006 | CN1814280A Regenerated human blood-platelet derivative growth factor gel |
| 08/09/2006 | CN1814279A Regenerated human alkali fiber-cell growth factor gel former and preparing method |
| 08/09/2006 | CN1814278A Iirudo-seu-whitmania essence inhalant and preparing method |
| 08/09/2006 | CN1814277A Use of methionine enkephalin in preparation of medicine for reducing toxic and side effect of chemical or radioactive therapy |
| 08/09/2006 | CN1814276A Nerve-protection function of thymosin beta 10 |
| 08/09/2006 | CN1814275A Nano compound eye-drop containing piptide-like medicine and preparing method |
| 08/09/2006 | CN1814209A Drunk-sobering tablet production method |
| 08/09/2006 | CN1814197A Use of alpha-amylase inribitor in medicine for preventing and treating hyper lipermia and athereosclerosis |
| 08/09/2006 | CN1813940A Weight-reducing jelly |
| 08/09/2006 | CN1813774A Composition containing ganglioside and trivalent chromium and its use |
| 08/09/2006 | CN1813699A Medicinal composition |
| 08/09/2006 | CN1268762C Corn peptide and its preparation and use |
| 08/09/2006 | CN1268753C Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/09/2006 | CN1268748C Viral vaccine |
| 08/09/2006 | CN1268744C Novel neurotrophic factors |
| 08/09/2006 | CN1268743C genetic construct for coding cell targeting part and heterologous precursor activating enzyme, and its application |
| 08/09/2006 | CN1268741C Therapy for 'alpha'-galactosidase deficiency |
| 08/09/2006 | CN1268738C Cytoxtoxic T lymphocytes |
| 08/09/2006 | CN1268645C Therapeutic compounds comprised of anti-FC receptor binding agents |
| 08/09/2006 | CN1268641C 载脂蛋白类似物 Apolipoprotein analogues |